Polymorphisms and expression pattern of circular RNA circ-ITCH contributes to the carcinogenesis of hepatocellular carcinoma.

Polymorphisms and expression pattern of circular RNA circ-ITCH contributes to the carcinogenesis of hepatocellular carcinoma.
复制标题

圆形RNA电路的多态性和表达模式有助于肝细胞癌的癌变。

DOI:
10.18632/oncotarget.18327
复制
发表时间:
2017-07-18
期刊:
影响因子:
--
通讯作者:
Ye H
Ye H
中科院分区:
其他
文献类型:
--
作者:
Guo W;Zhang J;Zhang D;Cao S;Li G;Zhang S;Wang Z;Wen P;Yang H;Shi X;Pan J;Ye H

文献摘要

参考文献

被引文献

相似文献

肝细胞癌 (HCC) 是全球第六大常见癌症,也是癌症相关死亡的第三大原因。最近的研究发现,circ-ITCH 通过抑制 Wnt/β-Catenin 通路来抑制多种癌症的增殖。在当前的研究中,进行了遗传关联研究和流行病学随访研究,以描述circ-ITCH在HCC发生和进展中的作用。我们发现rs10485505(调整后OR=1.18;95%CI=1.06-1.31;P值=3.1×10-3)和rs4911154(调整后OR=1.27;95%CI=1.14-1.43;P值=3.7×10-5)与HCC风险增加显着相关。 HCC组织中circ-ITCH的表达水平显着低于癌旁组织(P值<0.001)。 Cox回归分析表明,circ-ITCH的高表达与HCC的良好生存相关(HR=0.45;95% CI=0.29-0.68;P值<0.001)。这些结果表明circ-ITCH可能对HCC具有抑制作用,可作为HCC患者的易感性和预后生物标志物。
Hepatocellular carcinoma (HCC) ranks the sixth most common cancer and the third cause of cancer-related mortality worldwide. Recent studies identified that circ-ITCH Suppresses mutiple cancers proliferation via inhibiting the Wnt/beta-Catenin pathway. In current study, conducted a genetic association study together with epidemiological follow-up study to delineate the role of circ-ITCH in the development and progression of HCC. we found rs10485505 (adjusted OR =1.18; 95% CI=1.06-1.31; P value =3.1×10-3) and rs4911154 (adjusted OR =1.27; 95% CI=1.14-1.43; P value =3.7×10-5) were significantly associated with increased HCC risk. The expression level of circ-ITCH was significantly lower in HCC tissues, compared with that in adjacent tissues (P value < 0.001). Cox regression analysis indicated that high expression of circ-ITCH was associated with favorable survival of HCC (HR=0.45; 95% CI=0.29-0.68; P value < 0.001). These results indicate that circ-ITCH may have an inhibitory effect on HCC, and could serve as susceptibility and prognostic biomarkers for HCC patients.
DOI: 10.18632/oncotarget.10077
发表时间: 2016-08-02
期刊: Oncotarget
影响因子: --
作者:
Kaibori M;Sakai K;Ishizaki M;Matsushima H;De Velasco MA;Matsui K;Iida H;Kitade H;Kwon AH;Nagano H;Wada H;Haji S;Tsukamoto T;Kanazawa A;Takeda Y;Takemura S;Kubo S;Nishio K
通讯作者: Nishio K
DOI: 10.18632/oncotarget.9232
发表时间: 2016-07-12
期刊: Oncotarget
影响因子: --
作者:
Kovacs D;Migliano E;Muscardin L;Silipo V;Catricalà C;Picardo M;Bellei B
通讯作者: Bellei B
DOI: 10.18632/oncotarget.3469
发表时间: 2015-03-20
期刊: Oncotarget
影响因子: --
作者:
Li F;Zhang L;Li W;Deng J;Zheng J;An M;Lu J;Zhou Y
通讯作者: Zhou Y
DOI: 10.1101/gr.137323.112
发表时间: 2012-09
期刊: Genome research
影响因子: 7
作者:
Boyle AP;Hong EL;Hariharan M;Cheng Y;Schaub MA;Kasowski M;Karczewski KJ;Park J;Hitz BC;Weng S;Cherry JM;Snyder M
通讯作者: Snyder M
DOI: 10.18632/oncotarget.10399
发表时间: 2016-08-23
期刊: Oncotarget
影响因子: --
作者:
Li W;Li M;Liao D;Lu X;Gu X;Zhang Q;Zhang Z;Li H
通讯作者: Li H